相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。AKT regulation of mesothelial-to-mesenchymal transition in peritoneal dialysis is modulated by smurf2 and deubiquitinating enzyme USP4
Li Xiao et al.
BMC CELL BIOLOGY (2015)
PTEN Inhibits High Glucose-Induced Phenotypic Transition in Podocytes
Lingling Xing et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
Animal Models of Peritoneal Dialysis: Thirty Years of Our Own Experience
Krzysztof Pawlaczyk et al.
BIOMED RESEARCH INTERNATIONAL (2015)
mTOR Regulate EMT Through RhoA and Rac1 Pathway in Prostate Cancer
XianGuo Chen et al.
MOLECULAR CARCINOGENESIS (2015)
Selenium Suppresses Lipopolysaccharide-Induced Fibrosis in Peritoneal Mesothelial Cells Through Inhibition of Epithelial-to-Mesenchymal Transition
Jinyan Liu et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2014)
m-TOR inhibitors may be useful in the treatment of encapsulating peritoneal sclerosis (EPS)
Giovanni Maria Frasca et al.
JOURNAL OF NEPHROLOGY (2014)
Fasudil Inhibits Epithelial-Myofibroblast Trans differentiation of Human Renal Tubular Epithelial HK-2 Cells Induced by High Glucose
Lingjia Gu et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2013)
Peritoneal changes in patients on long-term peritoneal dialysis
Raymond T. Krediet et al.
NATURE REVIEWS NEPHROLOGY (2013)
Role of CIP4 in high glucose induced epithelial-mesenchymal transition of rat peritoneal mesothelial cells
Jian Zhang et al.
RENAL FAILURE (2013)
Rho family GTPases
Alan Hall
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Impact of Rapamycin on Peritoneal Fibrosis and Transport Function
T. Xu et al.
BLOOD PURIFICATION (2012)
Effect of sirolimus on the regression of peritoneal sclerosis in an experimental rat model
Mevlut Ceri et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2012)
Rapamycin inhibits transforming growth factor β-induced peritoneal angiogenesis by blocking the secondary hypoxic response
Yoshimi Sekiguchi et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Additive Effectiveness of Everolimus Plus Tamoxifen Therapy in Treatment of Encapsulating Peritoneal Sclerosis
Bulent Huddam et al.
RENAL FAILURE (2012)
Advances in Peritoneal Dialysis: A Review
Joanne M. Bargman
SEMINARS IN DIALYSIS (2012)
mTORC1 and mTORC2 Regulate EMT, Motility, and Metastasis of Colorectal Cancer via RhoA and Rac1 Signaling Pathways
Pat Gulhati et al.
CANCER RESEARCH (2011)
mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy
Asad Zeidan et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Treatment With Rapamycin Prevents Fibrosis in Tight-Skin and Bleomycin-Induced Mouse Models of Systemic Sclerosis
Ayumi Yoshizaki et al.
ARTHRITIS AND RHEUMATISM (2010)
Dissecting the role of mTOR: Lessons from mTOR inhibitors
Ryan J. O. Dowling et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Rapamycin Regulates Endothelial Cell Migration through Regulation of the Cyclin-dependent Kinase Inhibitor p27Kip1
Stephanie C. Moss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Rapamycin Inhibits Cytoskeleton Reorganization and Cell Motility by Suppressing RhoA Expression and Activity
Lei Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The Pathophysiology of the Peritoneal Membrane
Olivier Devuyst et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Smad3-dependent and -independent pathways are involved in peritoneal membrane injury
Pranali Patel et al.
KIDNEY INTERNATIONAL (2010)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
HGF and BMP-7 Ameliorate High Glucose-induced Epithelial-to-Mesenchymal Transition of Peritoneal Mesothelium
Min-A Yu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1
Margit Rosner et al.
HUMAN MOLECULAR GENETICS (2008)
Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport
G. del Peso et al.
KIDNEY INTERNATIONAL (2008)
Peritoneal changes after exposure to sterile solutions by catheter
Michael F. Flessner et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Cell size and invasion in TGF-β-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway
Samy Lamouille et al.
JOURNAL OF CELL BIOLOGY (2007)
Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients:: Pathologic significance and potential therapeutic interventions
Luiz S. Aroeira et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Nucleophosmin mediates mammalian target of rapamycin-dependent actin cytoskeleton dynamics and proliferation in neurofibromin-deficient astrocytes
Danielle K. Sandsmark et al.
CANCER RESEARCH (2007)
Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways
L. Liu et al.
ONCOGENE (2006)
Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis
M. J. Wu et al.
KIDNEY INTERNATIONAL (2006)
Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats
Nuria Lloberas et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
The epithelial-mesenchymal transition: new insights in signaling, development, and disease
JM Lee et al.
JOURNAL OF CELL BIOLOGY (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
RhoGTPase activation is a key step in renal epithelial mesenchymal transdifferentiation
S Patel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function
N Oshiro et al.
GENES TO CELLS (2004)
Cell migration: Integrating signals from front to back
AJ Ridley et al.
SCIENCE (2003)
Epithelial-mesenchymal transition and its implications for fibrosis
R Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Peritoneal dialysis solution biocompatibility: Definitions and evaluation strategies
CJ Holmes et al.
KIDNEY INTERNATIONAL (2003)
Central role for Rho in TGF-β1-induced α-smooth muscle actin expression during epithelial-mesenchymal transition
A Masszi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)
Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells
M Yañez-Mó et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells
S Mandl-Weber et al.
KIDNEY INTERNATIONAL (2002)
High glucose-induced PKC activation mediates TGF-β1 and fibronectin synthesis by peritoneal mesothelial cells
H Ha et al.
KIDNEY INTERNATIONAL (2001)
分享论文
